Welcome to Moffitt Cancer Center
 
Department of Cancer Imaging and Metabolism

The Department of Cancer Imaging and Metabolism was initiated in April 2008 with the hiring of Drs. Robert A. Gatenby and Robert J. Gillies as chair and vice-chair of Radiology. 

image

The Imaging Research Program was funded through investments from Moffitt Hospitals, Research Institute and Foundation.

The mission of this program is to develop a world-class translational cancer imaging research program.

Over the past year, we have made significant progress in establishing capabilities in Imaging Research, Training and Core Facilities.  We have also been successful in initiating an administrative structure to coordinate these activities.  In the next year, we expect to continue on the same path through the addition of new faculty, new trainees and new core capabilities.

The imaging research program is divided into three divisions:  Imaging Biomarkers, Imaging the Microenvironment,Targeting Agents and Buffer Therapy.  Each of these has independent funding and the participants in each theme have weekly group meetings.  In addition there is a monthly meeting of clinical radiology research.


Group Pictures (Click to view big picture)

Lab group pictures

MOFFITT Imaging Program – 2012
(L-R) Schmitt, Jeune-Smith, Khin, Cohen, Huynh, Xu, Estrella, Moberg, Bumpus, Foroutan, Bailey, Chen, *, Wojtkowiakk, Gatenby, Alfarouk, *, Silva, Gillies, Morse, Vishwakarma, Das, Grove, Kam, Balagurunathan,Rey, Huang, Gu, Tian, Kurtz, Martinez, Heine, Dutta, Li, Wang. 

Latest Group News  View All

image

11/2012: The Radiomics Workshop report 2012 is available[View]



image

Abstract accepted for WMIC 2012: Characterization of Multivalent Targeted Molecular Imaging Probes



image

Allison Cohen's abstract accepted for WMIC 2012: Discovery of Cell-Surface Markers for Molecular Imaging of Lung Cancer



image

Valerie Moberg's abstract accepted as oral presentation for WMIC 2012: Pharmacokinetics, Biodistribution and Tumor Specificity of a Fluorescent δ-Opioid Receptor Targeted Probe for Cancer Imaging